Heart-Health drug combo tested to ward off dementia in High-Risk group
NCT ID NCT07447206
First seen Mar 08, 2026 · Last updated May 01, 2026 · Updated 7 times
Summary
This small pilot study tests whether a pharmacist-led program to control high blood pressure and cholesterol can help people at risk for Alzheimer's disease. Ten participants, aged 50-75 and carrying the APOE ε4 gene, will take standard medications for six months. The goal is to see if this approach is feasible and improves heart health markers, which may lower dementia risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Sciences Building (CSC)
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.